Vision: Hygica biotech Ltd. was founded in Jan. 2007, which focuses on pharmaceutical business in Taiwan market. We are becoming one of growing fast biopharmaceutical companies by continuously updating our knowledge, and collaborating with international strategic alliances.
Mission: Provide effective, and safe medications to make people live better.
Core Competency: ․Efficient communication and integration of strategic partners ․Develop drug license in shorter time with relatively lower cost ․Continuous development of high potential product pipeline. ․Launch and Expanding product sales rapidly
Track records:
License in : Hygica has several contracts with Dae Hwa pharmaceutical from Korea, and Medis(Actavis) from Iceland to conduct product registration and sales promotion in Taiwan market.
Distrubution: Hygca has been exclusive distributor in Taiwan market for two items of SHISEIDO PHARMACEUTICAL INC. in Japan.
Management Team: Registration and marketing: 2 persons Management and accounting: 3 persons Sales team: 10 persons
Brief Description: Hygica biotech is a biopharmaceutical company focused on development and commercialization of the treatment of cardiovascular, diabetic, psychiatric, neurologic, oncology disorders and so on. We believe that our advanced understanding of the biopharmaceutical industry combined with our registration and clinical development expertise provide us with the capability to discover novel therapies. Hygica biotech focuses on capturing under-exploited pharmaceutical opportunities between Taiwan, and China.